Abstract
One of the characteristic features of asthma is a persistent pulmonary inflammation, with increased numbers of eosinophils and activated T-lymphocytes in the airways. T-helper cells of the Th2 phenotype play a pivotal role in the pathogenesis of asthma, and they are believed to orchestrate the asthmatic response by releasing a wide repertoire of cytokines. Herein, we describe the design, synthesis, and evaluation in models of allergic asthma of a locally active T-cell modulator, MLD987 (1). Compound 1 is a potent immunosuppressant that inhibits the activation, proliferation, and release of cytokines from T-cells with IC(50) values in the low nanomolar range. In a Brown-Norway rat model of allergic asthma, 1, when given into the airways by intratracheal administration (ED(50) = 1 mg/kg) or by inhalation (ED(50) = 0.4 mg/kg), potently reduced the influx of leukocytes into bronchoalveolar lavage fluid samples obtained from antigen-challenged animals. In contrast, 1 had an appreciably weaker activity in this model when given orally or intravenously. Pharmacokinetic evaluation in rat and rhesus monkey showed that 1 had both a low oral (2-4%) and a low pulmonary (7%, monkey) bioavailability. These findings are consistent with a local...Continue Reading
References
Feb 8, 1992·Lancet·A G AlexanderA B Kay
Jan 30, 1992·The New England Journal of Medicine·D S RobinsonA B Kay
Aug 1, 1987·The American Review of Respiratory Disease·J G KirbyP M O'Byrne
Sep 1, 1994·Trends in Pharmacological Sciences·G P Anderson, A J Coyle
Feb 1, 1994·The Journal of Allergy and Clinical Immunology·A HaczkuC Corrigan
May 1, 1997·Thorax·B S SihraA B Kay
Jul 15, 1997·Transplantation·W SchulerM H Schreier
Dec 31, 1997·American Journal of Respiratory Cell and Molecular Biology·T SchneiderA C Issekutz
Feb 25, 1998·Respiratory Medicine·H Derendorf
Apr 1, 1998·American Journal of Respiratory and Critical Care Medicine·P J BarnesW W Busse
Apr 30, 1998·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·D Y Leung, S J Szefler
Feb 18, 1999·Bioorganic & Medicinal Chemistry Letters·R HerspergerG Zenke
Jun 26, 1999·Clinical Transplantation·M L Henry
Sep 10, 1999·The Journal of Antibiotics·J J SanglierW Schilling
Dec 23, 1999·Medicinal Research Reviews·N Bodor, P Buchwald
Feb 26, 2000·Journal of Medicinal Chemistry·R HerspergerT Müller
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·J BousquetA M Vignola
Jun 16, 2001·European Journal of Pharmacology·S L UnderwoodC A Sargent
Apr 6, 2002·British Journal of Pharmacology·Alexandre TrifilieffUlf Neumann
Feb 21, 2003·Journal of Medicinal Chemistry·Tsvetelina LazarovaYat Sun Or
Sep 13, 2003·Journal of Immunological Methods·Annette Plesner
Citations
Nov 23, 2011·European Journal of Clinical Pharmacology·P ZarogoulidisK Zarogoulidis
Jul 1, 2007·Expert Opinion on Drug Discovery·Peter Buchwald
Apr 9, 2008·The Journal of Allergy and Clinical Immunology·David J CousinsTak H Lee
Aug 6, 2005·Pharmacology & Therapeutics·Michelle M Epstein
Jun 28, 2011·Immunopharmacology and Immunotoxicology·Haeyong LeeYoosik Yoon
Aug 7, 2013·Journal of Pharmaceutical and Biomedical Analysis·Cynthia D SommersMichael T Boyne
Apr 17, 2017·Bioorganic & Medicinal Chemistry Letters·Mitchell NambuMitchell Mutz
Jul 1, 2005·Expert Review of Clinical Immunology·Fulvio BraidoGiorgio Walter Canonica
Mar 25, 2017·Biology of Reproduction·Lili SheibaniDong-Bao Chen
Sep 21, 2007·Journal of the American Chemical Society·Satyamaheshwar PeddibhotlaDaniel Romo